UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 238

Sortiert nach

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

Liver international, 2016-12, Vol.36 (12), p.1755-1764

2016

Link zum Volltext

Verfügbarkeit prüfen

Moderate Risk of Hepatitis B Virus Reactivation in HBsAg - /HBcAb + Carriers Receiving Rituximab for Rheumatoid Arthritis

Scientific reports, 2020-02, Vol.10 (1), p.2456, Article 2456

2020

Link zum Volltext

Verfügbarkeit prüfen

HBV reactivation in HBsAg−/HBcAb+ rheumatoid arthritis patients receiving biologic/targeted synthetic DMARDs

Liver international, 2024-02, Vol.44 (2), p.497-507

2024

Link zum Volltext

Verfügbarkeit prüfen

Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment

Digestive diseases and sciences, 2021-11, Vol.66 (11), p.4026-4034

2021

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of regulatory T‐cell function in patients with chronic hepatitis B and C coinfection

Journal of viral hepatitis, 2020-08, Vol.27 (8), p.800-809

2020

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil gelatinase-associated lipocalin partly reflects the dynamic changes of renal function among chronic hepatitis C patients receiving direct-acting antivirals

PloS one, 2021-08, Vol.16 (8), p.e0256505

2021

Link zum Volltext

Verfügbarkeit prüfen

Regulatory T Cell Function Modulated After Successful Direct-Acting Antiviral Treatment for Chronic Hepatitis C Patients

Digestive diseases and sciences, 2020-05, Vol.65 (5), p.1385-1395

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

BMC infectious diseases, 2022-04, Vol.22 (1), p.351-351, Article 351

2022

Link zum Volltext

Verfügbarkeit prüfen

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

Viruses, 2022-08, Vol.14 (8), p.1812

2022

Link zum Volltext

Verfügbarkeit prüfen

The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma

Journal of the Formosan Medical Association, 2021-03, Vol.120 (3), p.965-973

2021

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort)

Journal of gastroenterology and hepatology, 2021-10, Vol.36 (10), p.2884-2892

2021

Link zum Volltext

Verfügbarkeit prüfen

Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy

BMC gastroenterology, 2021-01, Vol.21 (1), p.30-30, Article 30

2021

Link zum Volltext

Verfügbarkeit prüfen

Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan

Journal of the Formosan Medical Association, 2021-05, Vol.120 (5), p.1249-1258

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification and management of contraindicated drug–drug interactions through pharmaceutical care programs: Experience in direct-acting antivirals therapy

Journal of the Formosan Medical Association, 2022-01, Vol.121 (1), p.58-65

2022

Link zum Volltext

Verfügbarkeit prüfen

Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy

Journal of the Formosan Medical Association, 2020-10, Vol.119 (10), p.1483-1489

2020

Link zum Volltext

Verfügbarkeit prüfen

Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan

Journal of microbiology, immunology and infection, 2021-08, Vol.54 (4), p.588-595

2021

Link zum Volltext

Verfügbarkeit prüfen

The long-term outcomes of cirrhotic patients with pleural effusion

Saudi journal of gastroenterology, 2018-01, Vol.24 (1), p.46-51

2018

Link zum Volltext

Verfügbarkeit prüfen

Long‐term risk of end‐stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan

Journal of gastroenterology and hepatology, 2021-08, Vol.36 (8), p.2247-2254

2021

Link zum Volltext

Verfügbarkeit prüfen

Demonstration of color display metasurfaces via immersion lithography on a 12-inch silicon wafer

Optics express, 2018-07, Vol.26 (15), p.19548-19554

2018

Link zum Volltext

Verfügbarkeit prüfen

A High-Speed and Low-Breakdown-Voltage Silicon Avalanche Photodetector

IEEE photonics technology letters, 2014-03, Vol.26 (6), p.591-594

2014

Link zum Volltext
IEEE_Xplore

Limited drug–drug interaction of elbasvir/grazoprevir for chronic hepatitis C

Journal of the Formosan Medical Association, 2020-05, Vol.119 (5), p.933-940

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial

BMC cancer, 2019-03, Vol.19 (1), p.275-275, Article 275

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(220)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(183)
Life Sciences & Biomedicine
(146)
Humans
(104)
Female
(72)
Male
(70)
Middle Aged
(70)
Gastroenterology & Hepatology
(59)
Aged
(49)
Adult
(44)
Hepatitis C
(37)
Retrospective Studies
(30)
Antiviral Agents - Therapeutic Use
(28)
Hepatitis C, Chronic - Drug Therapy
(28)
Treatment Outcome
(27)
Hepatitis C Virus
(25)
Medicine
(24)
Technology
(24)
Patients
(23)
Risk Factors
(23)
Taiwan - Epidemiology
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

Moderate Risk of Hepatitis B Virus Reactivation in HBsAg - /HBcAb + Carriers Receiving Rituximab for Rheumatoid Arthritis

HBV reactivation in HBsAg−/HBcAb+ rheumatoid arthritis patients receiving biologic/targeted synthetic DMARDs

Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment

Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment

Characteristics of regulatory T‐cell function in patients with chronic hepatitis B and C coinfection

Neutrophil gelatinase-associated lipocalin partly reflects the dynamic changes of renal function among chronic hepatitis C patients receiving direct-acting antivirals

Regulatory T Cell Function Modulated After Successful Direct-Acting Antiviral Treatment for Chronic Hepatitis C Patients

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma

Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort)

Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy

Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan

Identification and management of contraindicated drug–drug interactions through pharmaceutical care programs: Experience in direct-acting antivirals therapy

Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan

Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy

Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan

The long-term outcomes of cirrhotic patients with pleural effusion

Long‐term risk of end‐stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan

Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan

Demonstration of color display metasurfaces via immersion lithography on a 12-inch silicon wafer

A High-Speed and Low-Breakdown-Voltage Silicon Avalanche Photodetector

Limited drug–drug interaction of elbasvir/grazoprevir for chronic hepatitis C

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial

Suchergebnisse filtern